文献速递胃肠动力与功能性疾病

空肠弯曲菌感染后肠易激综合征的美国队列研究

Postinfectious Irritable Bowel Syndrome After Campylobacter Infection.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

基于美国商业索赔数据库2010–2014年数据,将4143例空肠弯曲菌感染者与20491例无感染者按年龄组、性别和参保时长匹配。感染组1年肠易激综合征(IBS)发病率为33.1/1000,非感染组为5.9/1000,未调整风险比5.6(95%CI 4.3–7.3),调整医疗利用后Cox风险比4.6(95%CI 3.5–6.1)。排除90天内诊断IBS者后,1年发病率仍为16.7/1000 vs 3.9/1000,未调整风险比4.3(95%CI 3.0–6.2)。

要点

  • 空肠弯曲菌感染者1年IBS发病率显著高于未感染者。
  • 调整医疗利用后风险比仍达4.6,提示关联稳健。
  • 排除早期诊断后风险仍升高,支持感染后IBS概念。

核心结论

  • 空肠弯曲菌感染者发生IBS的风险显著高于未诊断该感染者,应重视其感染后IBS负担。

研究设计与样本

  • 最终匹配队列包括4143例空肠弯曲菌感染病例和20491例非感染对照,按年龄组、性别和参保时长个体匹配。

主要发现

  • 1年时感染组IBS发病率为33.1/1000,非感染组为5.9/1000,未调整风险比5.6(95%CI 4.3–7.3)。
  • 调整医疗利用后Cox比例风险比为4.6(95%CI 3.5–6.1)。
  • 排除90天内诊断IBS者后,1年发病率感染组16.7/1000、非感染组3.9/1000,未调整风险比4.3(95%CI 3.0–6.2)。

临床怎么用

  • 对空肠弯曲菌感染康复者应关注后续IBS症状,必要时进行随访评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Postinfectious irritable bowel syndrome (PI-IBS) is an important sequela of Campylobacter infection. Our goal is to estimate the incidence of Campylobacter-associated PI-IBS in the United States. METHODS: Data from January 1, 2010 to December 31, 2014, were obtained from the MarketScan Research Commercial Claims and Encounters Database. We identified patients with an encounter that included an International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code for "intestinal infection due to Campylobacter" (008.43) and individually matched them (on age group, sex, and length of enrollment) to a group of persons without a diagnosed Campylobacter infection (non-cases). The primary outcome of interest was a new diagnosis of IBS (International Classification of Diseases, Ninth Revision, Clinical Modification 564.1). RESULTS: Our final matched cohort included 4,143 cases and 20,491 non-cases. At 1 year, the incidence rate of IBS was 33.1 and 5.9 per 1,000 among cases and non-cases, respectively, with an unadjusted risk ratio of 5.6 (95% confidence interval [CI]: 4.3-7.3). After adjusting for healthcare utilization, the Cox proportional hazard ratio was 4.6 (95% CI: 3.5-6.1). Excluding those who received an IBS diagnosis within 90 days, the 1-year incidence rate of IBS was 16.7 and 3.9 per 1,000 among cases and non-cases, respectively, with an unadjusted risk ratio of 4.3 (95% CI: 3.0-6.2). DISCUSSION: Persons with a Campylobacter infection have a much higher risk of developing IBS compared with those not diagnosed with Campylobacter infection. The burden of Campylobacter-associated PI-IBS should be considered when assessing the overall impact of Campylobacter infections.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Scallan Walter EJ, Crim SM, Bruce BB, et al. Postinfectious Irritable Bowel Syndrome After Campylobacter Infection. Am J Gastroenterol. 2019. PMID: 31567167. doi:10.14309/ajg.0000000000000408

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。